Dr Khaled Greish

Our research focuses on exploiting tumor vascular characteristics to selectively target anticancer nanosystems to tumor tissues. The utmost goal of this research is to develop new remedies for cancer treatment with improved anticancer efficacy and safety. My group is also interested in investigating the biological safety of the emerging nanotechnology. Nano toxicology is becoming vital to avoid long term public harm and to safeguard the economic growth of nanotechnology.

Other Affiliations:
Adjunct Associate Professor, University of Utah, USA